The trajectory of Sildenafil presents a challenging picture for investors. While the initial release generated substantial profits, the end of its intellectual property protection opened the floodgates to off-brand https://bookmarksea.com/story21594404/viagra-and-the-pharmaceutical-industry-a-risky-opportunity